| 25.53 -0.07 (-0.27%) | 07-16 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 30.95  |
1-year : | 36.15 |
| Resists | First : | 26.5 |
Second : | 30.95 |
| Pivot price | 25.02 |
|||
| Supports | First : | 24.03 |
Second : | 22.51 |
| MAs | MA(5) : | 25.58 |
MA(20) : | 24.72 |
| MA(100) : | 22.34 |
MA(250) : | 21.23 |
|
| MACD | MACD : | 0.5  |
Signal : | 0.4 |
| %K %D | K(14,3) : | 77.7 |
D(3) : | 80.7 |
| RSI | RSI(14): 58.9 |
|||
| 52-week | High : | 26.5 | Low : | 17.12 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ STVN ] has closed below upper band by 24.5%. Bollinger Bands are 45.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 26.53 - 26.7 | 26.7 - 26.81 |
| Low: | 24.99 - 25.19 | 25.19 - 25.34 |
| Close: | 25.26 - 25.56 | 25.56 - 25.77 |
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.
Wed, 16 Jul 2025
TimesSquare Capital Management LLC Has $68.59 Million Stock Holdings in Stevanato Group S.p.A. (NYSE:STVN) - MarketBeat
Wed, 16 Jul 2025
Stevanato Group (NYSE:STVN) Reaches New 12-Month High - Here's Why - MarketBeat
Sun, 13 Jul 2025
Stevanato Group (NYSE:STVN) Reaches New 12-Month High - What's Next? - MarketBeat
Sun, 22 Jun 2025
Stevanato: Recovery Underway, Buy Confirmed (NYSE:STVN) - Seeking Alpha
Fri, 30 May 2025
Stevanato Group S.p.A. (STVN): A Bull Case Theory - Yahoo
Thu, 08 May 2025
Stevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025 - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 50 (M) |
| Shares Float | 49 (M) |
| Held by Insiders | 1.6 (%) |
| Held by Institutions | 112.6 (%) |
| Shares Short | 2,350 (K) |
| Shares Short P.Month | 2,710 (K) |
| EPS | 0.54 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.19 |
| Profit Margin | 11.1 % |
| Operating Margin | 13.9 % |
| Return on Assets (ttm) | 4.8 % |
| Return on Equity (ttm) | 9.1 % |
| Qtrly Rev. Growth | 8.6 % |
| Gross Profit (p.s.) | 6.31 |
| Sales Per Share | 22.58 |
| EBITDA (p.s.) | 4.91 |
| Qtrly Earnings Growth | 38.7 % |
| Operating Cash Flow | 184 (M) |
| Levered Free Cash Flow | -113 (M) |
| PE Ratio | 47.27 |
| PEG Ratio | 0 |
| Price to Book value | 4.91 |
| Price to Sales | 1.13 |
| Price to Cash Flow | 6.88 |
| Dividend | 0.05 |
| Forward Dividend | 0 |
| Dividend Yield | 0.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|